Emerging concepts for the in vitro derivation of murine haematopoietic stem and progenitor cells

Eva Garcia-Alegria; Sara Menegatti; Kiran Batta; Sara Cuvertino; Magdalena Florkowska; Valerie Kouskoff

doi:10.1002/1873-3468.12300

Emerging concepts for the in vitro derivation of murine haematopoietic stem and progenitor cells

Eva Garcia-Alegria, Sara Menegatti, Kiran Batta, Sara Cuvertino, Magdalena Florkowska, Valerie Kouskoff

Research output: Contribution to journal › Article › peer-review

125 Downloads (Pure)

Abstract

Well into the second decade of the 21st century, the field of regenerative medicine is bursting with hopes and promises to heal young and old. The bespoken generation of cells is thought to offer unprecedented cures for a vast range of diseases. Haematological disorders have already benefited tremendously from stem cell therapy in the form of bone marrow transplantation. However, lack of compatible donors often means that patients remain on transplantation waiting lists for too long. The in vitro derivation of haematopoietic stem cells offers the possibility to generate tailor-made cells for the treatment of these patients. Promising approaches to generate in vitro-derived blood progenitors include the directed differentiation of pluripotent stem cells and the reprogramming of somatic cells.

Original language	English
Journal	FEBS Letters
Early online date	12 Jul 2016
DOIs	https://doi.org/10.1002/1873-3468.12300
Publication status	Published - 2016

Access to Document

10.1002/1873-3468.12300

Accepted Garcia-Alegria et al FEBS letter review for submissionAccepted author manuscript, 179 KB

Cite this

@article{eaa95c462723422cbc086f592652b31a,

title = "Emerging concepts for the in vitro derivation of murine haematopoietic stem and progenitor cells",

abstract = "Well into the second decade of the 21st century, the field of regenerative medicine is bursting with hopes and promises to heal young and old. The bespoken generation of cells is thought to offer unprecedented cures for a vast range of diseases. Haematological disorders have already benefited tremendously from stem cell therapy in the form of bone marrow transplantation. However, lack of compatible donors often means that patients remain on transplantation waiting lists for too long. The in vitro derivation of haematopoietic stem cells offers the possibility to generate tailor-made cells for the treatment of these patients. Promising approaches to generate in vitro-derived blood progenitors include the directed differentiation of pluripotent stem cells and the reprogramming of somatic cells.",

author = "Eva Garcia-Alegria and Sara Menegatti and Kiran Batta and Sara Cuvertino and Magdalena Florkowska and Valerie Kouskoff",

note = "{\textcopyright} 2016 Federation of European Biochemical Societies.",

year = "2016",

doi = "10.1002/1873-3468.12300",

language = "English",

journal = "FEBS Letters",

issn = "0014-5793",

publisher = "John Wiley \& Sons Ltd",

}

TY - JOUR

T1 - Emerging concepts for the in vitro derivation of murine haematopoietic stem and progenitor cells

AU - Garcia-Alegria, Eva

AU - Menegatti, Sara

AU - Batta, Kiran

AU - Cuvertino, Sara

AU - Florkowska, Magdalena

AU - Kouskoff, Valerie

PY - 2016

Y1 - 2016

N2 - Well into the second decade of the 21st century, the field of regenerative medicine is bursting with hopes and promises to heal young and old. The bespoken generation of cells is thought to offer unprecedented cures for a vast range of diseases. Haematological disorders have already benefited tremendously from stem cell therapy in the form of bone marrow transplantation. However, lack of compatible donors often means that patients remain on transplantation waiting lists for too long. The in vitro derivation of haematopoietic stem cells offers the possibility to generate tailor-made cells for the treatment of these patients. Promising approaches to generate in vitro-derived blood progenitors include the directed differentiation of pluripotent stem cells and the reprogramming of somatic cells.

AB - Well into the second decade of the 21st century, the field of regenerative medicine is bursting with hopes and promises to heal young and old. The bespoken generation of cells is thought to offer unprecedented cures for a vast range of diseases. Haematological disorders have already benefited tremendously from stem cell therapy in the form of bone marrow transplantation. However, lack of compatible donors often means that patients remain on transplantation waiting lists for too long. The in vitro derivation of haematopoietic stem cells offers the possibility to generate tailor-made cells for the treatment of these patients. Promising approaches to generate in vitro-derived blood progenitors include the directed differentiation of pluripotent stem cells and the reprogramming of somatic cells.

UR - https://www.scopus.com/pages/publications/84994432459

U2 - 10.1002/1873-3468.12300

DO - 10.1002/1873-3468.12300

M3 - Article

C2 - 27404333

SN - 0014-5793

JO - FEBS Letters

JF - FEBS Letters

ER -

Emerging concepts for the in vitro derivation of murine haematopoietic stem and progenitor cells

Abstract

Access to Document

Other files and links

Fingerprint

Cite this